PKCα mediated induction of miR-101 in human hepatoma HepG2 cells

被引:43
|
作者
Chiang, Chao-Wei [1 ]
Huang, Yi [2 ]
Leong, Ka-Wai [2 ]
Chen, Lih-Chyang [3 ]
Chen, Hua-Chien [4 ]
Chen, Shu-Jen [4 ]
Chou, Chen-Kung [1 ,2 ]
机构
[1] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan
[2] Chang Gung Univ, Grad Inst Basic Med Sci, Dept Life Sci, Tao Yuan, Taiwan
[3] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Tao Yuan, Taiwan
[4] Chang Gung Univ, Mol Med Res Ctr, Genom Core Lab, Tao Yuan, Taiwan
关键词
PROTEIN-KINASE-C; HEPATOCELLULAR-CARCINOMA; GROWTH-INHIBITION; EPITHELIAL-CELLS; TUMOR-SUPPRESSOR; CANCER; MICRORNA-101; ACTIVATION; EXPRESSION; MECHANISM;
D O I
10.1186/1423-0127-17-35
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Protein Kinase C (PKC) is a serine/threonine kinase that involved in controlling of many cellular processes such as cell proliferation and differentiation. We have observed previously that TPA (12-O-tetradecanoylphorbol 13-acetate) induces cell cycle arrest in G0/G1 phase in human hepatoma HepG2 cells. However, is there any miRNA involved in PKCa mediated cell growth arrest is still unknown. Methods: We first surveyed 270 miRNA expression profiles in 20 pairs of human hepatoma tissues. We identified 11 up-regulated and 23 down-regulated miRNAs (FDR < = 0.01; fold-change > = 2) in human hepatoma tissue after Student's T-test and Mann-Whitney rank test. We then examined miRNAs expression profile in TPA treated HepG2 cells. Two miRNAs, miR-101, and miR-29c, were shown to be significantly down regulated in human hepatoma tissues and induced over 4-fold in HepG2 cells under TPA treatment. Results: In this study, we examined TPA regulated miRNA expression profile in human hepatoma HepG2 cells. We identified two miRNAs, 101 and 29c, were induced by TPA and down regulated in human hepatoma tissues suggest that they might play as tumor suppressor gene and in tumor formation of HCC. Since induction kinetics of miR-101 by TPA was much faster than miR-29c suggests that the induction of miR-101 may be the primary response of TPA treatment. We then further investigated how miR-101 was regulated by TPA. MiR-101 targets two subunits of PRC2 complex, enhancer of zeste homolog 2 (EZH2) and EED, and was shown to play as a tumor suppressor gene in human prostate, breast and liver cancers. The target sequence of miR-101 located in the 3' UTR of both EZH2 and EED's mRNA was identified by bioinformatic analysis and was validated by reporter luciferase activity assay. Then we showed that TPA not only up regulated miR-101 expression, but also reduced protein level of EZH2, EED and H3K27me3 in HepG2 cells. Using lenti-virus-mediated shRNA to knockdown endogenous PKCa expression, we observed that TPA induced growth arrest, elevation of miR-101 and reduction of EZH2, EED and H3K27me3 proteins were all PKCa dependent. Specific inhibitor of ERK completely blocked TPA induced miR-101 expression. Conclusions: Therefore, this is the first time to show that PKCa and ERK pathway play important role to activate miR-101 expression, reduce PRC2 complex and H3K27me3 level. This epigenetic regulatory pathway may represent a novel mechanism of carcinogenesis and deserve further investigation.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells
    Nikos J Tsagarakis
    Ioannis Drygiannakis
    Antonis G Batistakis
    George Kolios
    Elias A Kouroumalis
    World Journal of Gastroenterology, 2011, 17 (03) : 313 - 321
  • [22] microRNA-mediated resistance to hypoglycemia in the HepG2 human hepatoma cell line
    Ueki, Satomi
    Murakami, Yuko
    Yamada, Shoji
    Kimura, Masaki
    Saito, Yoshimasa
    Saito, Hidetsugu
    BMC CANCER, 2016, 16
  • [23] miR-101 Promotes Breast Cancer Cell Apoptosis by Targeting Janus Kinase 2
    Wang, Lu
    Li, Linqiang
    Guo, Rui
    Li, Xuelian
    Lu, Ying
    Guan, Xiaoxiang
    Gitau, Samuel Chege
    Wang, Leimin
    Xu, Chaoqian
    Yang, Baofeng
    Shan, Hongli
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2014, 34 (02) : 413 - 422
  • [24] Inhibitory effects of miR-101 overexpression on cervical cancer SiHa cells
    Liu, H.
    Zhao, J.
    Lv, J.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (02) : 236 - 240
  • [25] Cytotoxic Effect of Eucalyptus citriodora Resin on Human Hepatoma HepG2 Cells
    Shen, Kun-Hung
    Chen, Zong-Tsi
    Duh, Pin-Der
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2012, 40 (02): : 399 - 413
  • [26] Oridonin increases anticancer effects of lentinan in HepG2 human hepatoblastoma cells
    Sun, Zhiqiang
    Han, Qinghe
    Duan, Liwei
    Yuan, Qinghai
    Wang, Hui
    ONCOLOGY LETTERS, 2018, 15 (02) : 1999 - 2005
  • [27] Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells
    Quagliariello, Vincenzo
    Masarone, Mario
    Armenia, Emilia
    Giudice, Aldo
    Barbarisi, Manlio
    Caraglia, Michele
    Barbarisi, Alfonso
    Persico, Marcello
    ONCOLOGY REPORTS, 2019, 41 (03) : 1476 - 1486
  • [28] miR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1
    Sun, Quanquan
    Liu, Tongxin
    Zhang, Tian
    Du, Shasha
    Xie, Guozhu
    Lin, Xiaoshan
    Chen, Longhua
    Yuan, Yawei
    MOLECULAR MEDICINE REPORTS, 2015, 11 (05) : 3330 - 3336
  • [29] MiR-101 Is Involved in Human Breast Carcinogenesis by Targeting Stathmin1
    Wang, Rui
    Wang, Hong-Bin
    Hao, Chan Juan
    Cui, Yi
    Han, Xiao-Chen
    Hu, Yi
    Li, Fei-Feng
    Xia, Hong-Fei
    Ma, Xu
    PLOS ONE, 2012, 7 (10):
  • [30] Apoptosis induction in human hepatoma cell line HepG2 cells by trans-Anethole via activation of mitochondria-mediated apoptotic pathways
    Harakeh, Steve
    Al-Raddadi, Rajaa
    Alamri, Turki
    Al-Jaouni, Soad
    Qari, Mohammed
    Qari, Yousef
    Kumar, Ajay
    Tashkandi, Hanaa M.
    Moulay, Mohammed
    Aldahlawi, Alia M.
    Slama, Petr
    Haque, Shafiul
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 165